Cardiolipin signaling mechanisms: Collapse of asymmetry and oxidation

Antioxidants and Redox Signaling

Volumn 22, Issue 18, 2015, Pages 1667-1680

  Kagan, Valerian E ^a,b   Tyurina, Yulia Y ^a   Tyurin, Vladimir A ^a   Mohammadyani, Dariush ^a   Angeli, Jose Pedro Friedmann ^c   Baranov, Sergei V ^b   Klein Seetharaman, Judith ^d   Friedlander, Robert M ^b   Mallampalli, Rama K ^b   Conrad, Marcus ^c   Bayir, Hülya ^b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

^d UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLIPIN; LIPID; MEMBRANE PHOSPHOLIPID;

APOPTOSIS; BILAYER MEMBRANE; BRAIN MITOCHONDRION; CELL FUNCTION; CELL INTERACTION; CELL METABOLISM; CELLULAR DISTRIBUTION; CHEMICAL ENVIRONMENT; CHIRALITY; EUKARYOTE; EUKARYOTIC CELL; HUMAN; HYDROLYSIS; LIPID METABOLISM; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; MITOPHAGY; NONHUMAN; OUTER MEMBRANE; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROKARYOTE; PROTEIN BINDING; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; CHEMISTRY; METABOLISM; MITOCHONDRION; OXIDATION REDUCTION REACTION; PROKARYOTIC CELL;

EUKARYOTA; PROKARYOTA;

ANIMALS; APOPTOSIS; CARDIOLIPINS; HUMANS; HYDROLYSIS; LIPID METABOLISM; MITOCHONDRIA; MITOCHONDRIAL MEMBRANES; OXIDATION-REDUCTION; PROKARYOTIC CELLS; SIGNAL TRANSDUCTION;

EID: 84930617981     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2014.6219     Document Type: Review

References (104)

1. Arechaga I. Membrane invaginations in bacteria and mitochondria: common features and evolutionary scenarios. J Mol Microbiol Biotechnol 23: 13-23, 2013.
2. Atkinson J, Kapralov AA, Yanamala N, Tyurina YY, Amoscato AA, Pearce L, Peterson J, Huang Z, Jiang J, Samhan-Arias AK, Maeda A, Feng W, Wasserloos K, Belikova NA, Tyurin VA, Wang H, Fletcher J, Wang Y, Vlasova, II, Klein-Seetharaman J, Stoyanovsky DA, Bayir H, Pitt BR, Epperly MW, Greenberger JS, and Kagan VE. A mitochondria-targeted inhibitor of cytochrome c peroxidase mitigates radiation-induced death. Nat Commun 2: 497, 2011.
3. Battistuzzi G, Borsari M, Cowan JA, Ranieri A, and Sola M. Control of cytochrome c redox potential: axial ligation and protein environment effects. J Am Chem Soc 124: 5315-5324, 2002.
4. Bayir H, Tyurin VA, Tyurina YY, Viner R, Ritov V, Amoscato AA, Zhao Q, Zhang XJ, Janesko-Feldman KL, Alexander H, Basova LV, Clark RS, Kochanek PM, and Kagan VE. Selective early cardiolipin peroxidation after traumatic brain injury: an oxidative lipidomics analysis. Ann Neurol 62: 154-169, 2007.
5. Belikova NA, Vladimirov YA, Osipov AN, Kapralov AA, Tyurin VA, Potapovich MV, Basova LV, Peterson J, Kurnikov IV, and Kagan VE. Peroxidase activity and structural transitions of cytochrome c bound to cardiolipincontaining membranes. Biochemistry 45: 4998-5009, 2006.
6. Belikova NA, Jiang JF, Stoyanovsky DA, Glumac A, Bayir H, Greenberger JS, and Kagan VE. Mitochondria-targeted (2-hydroxyamino-vinyl)-triphenyl-phosphoniumreleases no center dot and protects mouse embryonic cells against irradiation- induced apoptosis.FEBS Lett 583: 1945-1950, 2009.
7. Belikova NA, Tyurina YY, Borisenko G, Tyurin V, Samhan Arias AK, Yanamala N, Furtmuller PG, Klein- Seetharaman J, Obinger C, and Kagan VE. Heterolytic reduction of fatty acid hydroperoxides by cytochrome c/ cardiolipin complexes: antioxidant function in mitochondria. J Am Chem Soc 131: 11288-11289, 2009.
8. Birk AV, Chao WM, Bracken C, Warren JD, and Szeto HH. Targeting mitochondrial cardiolipin and the cytochrome c/cardiolipin complex to promote electron transport and optimize mitochondrial ATP synthesis. Br J Pharmacol 171: 2017-2028, 2014.
9. Blake R and Trounce IA. Mitochondrial dysfunction and complications associated with diabetes. Biochim Biophys Acta 1840: 1404-1412, 2014.
10. Bozza PT, Bakker-Abreu I, Navarro-Xavier RA, and Bandeira-Melo C. Lipid body function in eicosanoid synthesis: an update. Prostaglandins Leukot Essent Fatty Acids 85: 205-213, 2011.
11. Campello S, Strappazzon F, and Cecconi F. Mitochondrial dismissal in mammals, from protein degradation to mitophagy. Biochim Biophys Acta 1837: 451-460, 2014.
12. Chen YR and Zweier JL. Cardiac mitochondria and reactive oxygen species generation. Circ Res 114: 524-537, 2014.
13. Cheng H, Mancuso DJ, Jiang X, Guan S, Yang J, Yang K, SunG, GrossRW, andHanX.Shotgun lipidomics reveals the temporally dependent, highly diversified cardiolipin profile in the mammalian brain: temporally coordinated postnatal diversification of cardiolipin molecular species with neuronal remodeling. Biochemistry 47: 5869-5880, 2008.
14. Chu CT, Ji J, Dagda RK, Jiang JF, Tyurina YY, Kapralov AA, Tyurin VA, Yanamala N, Shrivastava IH, Mohammadyani D, Qiang Wang KZ, Zhu J, Klein-Seetharaman J, Balasubramanian K, Amoscato AA, Borisenko G, Huang Z, GusdonAM, Cheikhi A, Steer EK, Wang R, BatyC, Watkins S, Bahar I, Bayir H, and Kagan VE. Cardiolipin externalization to the outer mitochondrial membrane acts as an elimination signal for mitophagy in neuronal cells. Nat Cell Biol 15: 1197-1205, 2013.
15. Claypool SM. Cardiolipin, a critical determinant of mitochondrial carrier protein assembly and function. Biochim Biophys Acta 1788: 2059-2068, 2009.
16. Claypool SM, Whited K, Srijumnong S, Han XL, and Koehler CM. Barth syndrome mutations that cause tafazzin complex lability. J Cell Biol 192: 447-462, 2011.
17. Claypool SM and Koehler CM. The complexity of cardiolipin in health and disease. Trends Biochem Sci 37: 32- 41, 2012.
18. Cortese JD, Voglino AL, and Hackenbrock CR. Ionic strength of the intermembrane space of intact mitochondria as estimated with fluorescein-BSA delivered by low pH fusion. J Cell Biol 113: 1331-1340, 1991.
19. Crimi M and Esposti MD. Apoptosis-induced changes in mitochondrial lipids. Biochim Biophys Acta 1813: 551- 557, 2011.
20. Curtis MM and Sperandio V. A complex relationship: the interaction among symbiotic microbes, invading pathogens, and their mammalian host. Mucosal Immunol 4: 133-138, 2011.
21. Dalebroux ZD, Matamouros S, Whittington D, Bishop RE, and Miller SI. Phopq regulates acidic glycerophospholipid content of the Salmonella typhimurium outer membrane. Proc Natl Acad Sci U S A 111: 1963-1968, 2014.
22. Deamer DW. Role of amphiphilic compounds in the evolution of membrane structure on the early earth. Orig Life Evol Biosph 17: 3-25, 1986.
23. Dennis EA, Cao J, Hsu YH, Magrioti V, and Kokotos G. Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention. Chem Rev 111: 6130-6185, 2011.
24. Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS, Morrison B, III, and Stockwell BR. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149: 1060-1072, 2012.
25. Emelyanov VV. Rickettsiaceae, rickettsia-like endosymbionts, and the origin of mitochondria. Biosci Rep 21: 1-17, 2001.
26. Garcia Fernandez M, Troiano L, Moretti L, Nasi M, Pinti M, Salvioli S, Dobrucki J, and Cossarizza A. Early changes in intramitochondrial cardiolipin distribution during apoptosis. Cell Growth Differ 13: 449-455, 2002.
27. Gold VA, Robson A, Bao H, Romantsov T, Duong F, and Collinson I. The action of cardiolipin on the bacterial translocon. Proc Natl Acad Sci U S A 107: 10044-10049, 2010.
28. Gonzalvez F, Schug ZT, Houtkooper RH, MacKenzie ED, Brooks DG, Wanders RJ, Petit PX, Vaz FM, and Gottlieb E. Cardiolipin provides an essential activating platform for caspase-8 on mitochondria. J Cell Biol 183: 681-696, 2008.
29. Gutierrez J, Ballinger SW, Darley-Usmar VM, and Landar A. Free radicals, mitochondria, and oxidized lipids: the emerging role in signal transduction in vascular cells. Circ Res 99: 924-932, 2006.
30. Haines TH. A new look at cardiolipin. Biochim Biophys Acta 1788: 1997-2002, 2009.
31. Hammond VJ, Morgan AH, Lauder S, Thomas CP, Brown S, Freeman BA, Lloyd CM, Davies J, Bush A, Levonen AL, Kansanen E, Villacorta L, Chen YE, Porter N, Garcia-Diaz YM, Schopfer FJ, and O'Donnell VB. Novel keto-phospholipids are generated by monocytes and macrophages, detected in cystic fibrosis, and activate peroxisome proliferator-activated receptor-gamma. J Biol Chem 287: 41651-41666, 2012.
32. Horvath SE and Daum G. Lipids of mitochondria. Prog Lipid Res 52: 590-614, 2013.
33. Hsu FF, Turk J, Rhoades ER, Russell DG, Shi Y, and Groisman EA. Structural characterization of cardiolipin by tandem quadrupole and multiple-stage quadrupole iontrap mass spectrometry with electrospray ionization. J Am Soc Mass Spectrom 16: 491-504, 2005.
34. Hutchins PM and Murphy RC. Cholesteryl ester acyl oxidation and remodeling in murine macrophages: formation of oxidized phosphatidylcholine. J Lipid Res 53: 1588-1597, 2012.
35. Huttemann M, Pecina P, Rainbolt M, Sanderson TH, Kagan VE, Samavati L, Doan JW, and Lee I. The multiple functions of cytochrome c and their regulation in life and death decisions of the mammalian cell: from respiration to apoptosis. Mitochondrion 11: 369-381, 2011.
36. Ichinohe T, Yamazaki T, Koshiba T, and Yanagi Y. Mitochondrial protein mitofusin 2 is required for NLRP3 inflammasome activation after RNA virus infection. Proc Natl Acad Sci U S A 110: 17963-17968, 2013.
37. Ivanetich KM, Bradshaw JJ, and Kaminsky LS. Methionine sulfoxide cytochrome c. Biochemistry 15: 1144-1153, 1976.
38. Ji J, Kline AE, Amoscato A, Samhan-Arias AK, Sparvero LJ, Tyurin VA, Tyurina YY, Fink B, Manole MD, Puccio AM, Okonkwo DO, Cheng JP, Alexander H, Clark RS, Kochanek PM, Wipf P, Kagan VE, and Bayir H. Lipidomics identifies cardiolipin oxidation as a mitochondrial target for redox therapy of brain injury. Nat Neurosci 15: 1407-1413, 2012.
39. Jiang J, Stoyanovsky DA, Belikova NA, Tyurina YY, Zhao Q, Tungekar MA, Kapralova V, Huang Z, Mintz AH, Greenberger JS, and Kagan VE. A mitochondria-targeted triphenylphosphonium-conjugated nitroxide functions as a radioprotector/mitigator. Radiat Res 172: 706-717, 2009.
40. Jiang J, Maeda A, Ji J, Baty CJ, Watkins SC, Greenberger JS, and Kagan VE. Are mitochondrial reactive oxygen species required for autophagy? Biochem Biophys Res Commun 412: 55-60, 2011.
41. Jiang JF, Bakan A, Kapralov AA, Silva KI, Huang ZT, Amoscato AA, Peterson J, Garapati VK, Saxena S, Bayir H, Atkinson J, Bahar I, and Kagan VE. Designing inhibitors of cytochrome c/cardiolipin peroxidase complexes: mitochondria-targeted imidazole-substituted fatty acids. Free Radic Biol Med 71: 221-230, 2014.
42. Kagan VE. Lipid Peroxidation in Biomembranes. Boca Raton, FL: CRC Press, 1988.
43. Kagan VE, Borisenko GG, Serinkan BF, Tyurina YY, Tyurin VA, Jiang J, Liu SX, Shvedova AA, Fabisiak JP, Uthaisang W, and Fadeel B. Appetizing rancidity of apoptotic cells for macrophages: oxidation, externalization, and recognition of phosphatidylserine. Am J Physiol Lung Cell Mol Physiol 285: L1-L17, 2003.
44. Kagan VE, Tyurin VA, Jiang J, Tyurina YY, Ritov VB, Amoscato AA, Osipov AN, Belikova NA, Kapralov AA, Kini V, Vlasova, II, Zhao Q, Zou M, Di P, Svistunenko DA, Kurnikov IV, and Borisenko GG. Cytochrome c acts as a cardiolipin oxygenase required for release of proapoptotic factors. Nat Chem Biol 1: 223-232, 2005.
45. Kagan VE, Bayir HA, Belikova NA, Kapralov O, Tyurina YY, Tyurin VA, Jiang J, Stoyanovsky DA, Wipf P, Kochanek PM, Greenberger JS, Pitt B, Shvedova AA, and Borisenko G. Cytochrome c/cardiolipin relations in mitochondria: a kiss of death. Free Radic Biol Med 46: 1439-1453, 2009.
46. Kagan VE, Chu CT, Tyurina YY, Cheikhi A, and Bayir H. Cardiolipin asymmetry, oxidation and signaling. Chem Phys Lipids 179: 64-69, 2014.
47. Kapralov AA, Kurnikov IV, Vlasova, II, Belikova NA, Tyurin VA, Basova LV, Zhao Q, Tyurina YY, Jiang J, Bayir H, Vladimirov YA, and Kagan VE. The hierarchy of structural transitions induced in cytochrome c by anionic phospholipids determines its peroxidase activation and selective peroxidation during apoptosis in cells. Biochemistry 46: 14232-14244, 2007.
48. Kasahara A and Scorrano L. Mitochondria: from cell death executioners to regulators of cell differentiation. Trends Cell Biol 24: 761-770, 2014.
49. Kiebish MA, Han X, and Seyfried TN. Examination of the brain mitochondrial lipidome using shotgun lipidomics. Methods Mol Biol 579: 3-18, 2009.
50. Kiebish MA, Yang K, Liu X, Mancuso DJ, Guan S, Zhao Z, Sims HF, Cerqua R, Cade WT, Han X, and Gross RW. Dysfunctional cardiac mitochondrial bioenergetic, lipidomic, and signaling in a murine model of Barth syndrome. J Lipid Res 54: 1312-1325, 2013.
51. Kobe MJ, Neau DB, Mitchell CE, Bartlett SG, and Newcomer ME. The structure of human 15-lipoxygenase-2 with a substrate mimic. J Biol Chem 289: 8562-8569, 2014.
52. Kozjak-Pavlovic V, Ross K, and Rudel T. Import of bacterial pathogenicity factors into mitochondria. Curr Opin Microbiol 11: 9-14, 2008.
53. Lanciano P, Khalfaoui-Hassani B, Selamoglu N, Ghelli A, Rugolo M, and Daldal F. Molecular mechanisms of superoxide production by complex III: a bacterial versus human mitochondrial comparative case study. Biochim Biophys Acta 1827: 1332-1339, 2013.
54. Li GL, Chen SL, Thompson MN, and Greenberg ML. New insights into the regulation of cardiolipin biosynthesis in yeast: implications for Barth syndrome. Biochim Biophys Acta 1771: 432-441, 2007.
55. Louie GV and Brayer GD. High-resolution refinement of yeast iso-1-cytochrome c and comparisons with other eukaryotic cytochromes c. J Mol Biol 214: 527-555, 1990.
56. Luisi PL, Walde P, and Oberholzer T. Lipid vesicles as possible intermediates in the origin of life. Curr Opinion Coll Interface Sci 4: 33-39, 1999.
57. Ma L, Vaz FM, Gu Z, Wanders RJ, and Greenberg ML. The human TAZ gene complements mitochondrial dysfunction in the yeast taz1delta mutant. Implications for Barth syndrome. J Biol Chem 279: 44394-44399, 2004.
58. Maloney E, Madiraju SC, Rajagopalan M, and Madiraju M. Localization of acidic phospholipid cardiolipin and DnaA in mycobacteria. Tuberculosis (Edinb) 91 Suppl 1: S150-S155, 2011.
59. Margoliash E and Schejter A. Cytochrome c. Adv Protein Chem 21: 113-286, 1966.
60. McClelland LJ, Mou TC, Jeakins-Cooley ME, Sprang SR, and Bowler BE. Structure of a mitochondrial cytochrome c conformer competent for peroxidase activity. Proc Natl Acad Sci U S A 111: 6648-6653, 2014.
61. Mileykovskaya E and Dowhan W. Cardiolipin membrane domains in prokaryotes and eukaryotes. Biochim Biophys Acta 1788: 2084-2091, 2009.
62. Mileykovskaya E and Dowhan W. Cardiolipin-dependent formation of mitochondrial respiratory supercomplexes. Chem Phys Lipids 179: 42-48, 2014.
63. Moon SH, Jenkins CM, Liu X, Guan S, Mancuso DJ, and Gross RW. Activation of mitochondrial calciumindependent phospholipase a2gamma (ipla2gamma) by divalent cations mediating arachidonate release and production of downstream eicosanoids. J Biol Chem 287: 14880-14895, 2012.
64. Nomura K, Imai H, Koumura T, Kobayashi T, and Nakagawa Y. Mitochondrial phospholipid hydroperoxide glutathione peroxidase inhibits the release of cytochrome c from mitochondria by suppressing the peroxidation of cardiolipin in hypoglycaemia-induced apoptosis. Biochem J 351: 183-193, 2000.
65. O'Neill LA. Cardiolipin and the nlrp3 inflammasome. Cell Metab 18: 610-612, 2013.
66. Oliver PM, Crooks JA, Leidl M, Yoon EJ, Saghatelian A, and Weibel DB. Localization of anionic phospholipids in escherichia coli cells. J Bacteriol 196: 3386-3398, 2014.
67. Osman C, Voelker DR, and Langer T. Making heads or tails of phospholipids in mitochondria. J Cell Biol 192: 7- 16, 2011.
68. Panov A, Dikalov S, Shalbuyeva N, Taylor G, Sherer T, and Greenamyre JT. Rotenone model of parkinson disease: multiple brain mitochondria dysfunctions after short term systemic rotenone intoxication. J Biol Chem 280: 42026-42035, 2005.
69. Paradies G, Paradies V, De Benedictis V, Ruggiero FM, and Petrosillo G. Functional role of cardiolipin in mitochondrial bioenergetics. Biochim Biophys Acta 1837: 408-417, 2014.
70. Patil VA and Greenberg ML. Cardiolipin-mediated cellular signaling. Adv Exp Med Biol 991: 195-213, 2013.
71. Rapoport SM, Schewe T, Wiesner R, Halangk W, Ludwig P, Janickehohne M, Tannert C, Hiebsch C, and Klatt D. Lipoxygenase of reticulocytes-purification, characterization and biological dynamics of the lipoxygenase-its identity with the respiratory inhibitors of the reticulocyte. Eur J Biochem 96: 545-561, 1979.
72. Ren M, Phoon CK, and Schlame M. Metabolism and function of mitochondrial cardiolipin. Prog Lipid Res 55C: 1-16, 2014.
73. Rouzer CA and Marnett LJ. Endocannabinoid oxygenation by cyclooxygenases, lipoxygenases, and cytochromes p450: cross-talk between the eicosanoid and endocannabinoid signaling pathways. Chem Rev 111: 5899-5921, 2011.
74. Schagger H. Respiratory chain supercomplexes of mitochondria and bacteria. Biochim Biophys Acta 1555: 154-159, 2002.
75. Schlame M, Shanske S, Doty S, Konig T, Sculco T, Di- Mauro S, and Blanck TJ. Microanalysis of cardiolipin in small biopsies including skeletal muscle from patients with mitochondrial disease. J Lipid Res 40: 1585-1592, 1999.
76. Schlame M. Cardiolipin synthesis for the assembly of bacterial and mitochondrial membranes. J Lipid Res 49: 1607-1620, 2008.
77. Schlattner U, Tokarska-Schlattner M, Ramirez S, Tyurina YY, Amoscato AA, Mohammadyani D, Huang Z, Jiang J, Yanamala N, Seffouh A, Boissan M, Epand RF, Epand RM, Klein-Seetharaman J, Lacombe ML, and Kagan VE. Dual function of mitochondrial nm23-h4 protein in phosphotransfer and intermembrane lipid transfer: a cardiolipin- dependent switch. J Biol Chem 288: 111-121, 2013.
78. Schumacker PT, Gillespie MN, Nakahira K, Choi AM, Crouser ED, Piantadosi CA, and Bhattacharya J. Mitochondria in lung biology and pathology: more than just a powerhouse. Am J Physiol Lung Cell Mol Physiol 306: L962-L974, 2014.
79. Seiler A, Schneider M, Forster H, Roth S, Wirth EK, Culmsee C, Plesnila N, Kremmer E, Radmark O, Wurst W, Bornkamm GW, Schweizer U, and Conrad M. Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent- and aif-mediated cell death. Cell Metab 8: 237-248, 2008.
80. Serhan CN, Chiang N, and Van Dyke TE. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 8: 349-361, 2008.
81. Sparagna GC and Lesnefsky EJ. Cardiolipin remodeling in the heart. J Cardiovasc Pharmacol 53: 290-301, 2009.
82. Stables MJ and Gilroy DW. Old and new generation lipid mediators in acute inflammation and resolution. Prog Lipid Res 50: 35-51, 2011.
83. Stevens JM. Cytochrome c as an experimental model protein. Metallomics 3: 319-322, 2011.
84. Tian HF, Feng JM, and Wen JF. The evolution of cardiolipin biosynthesis and maturation pathways and its implications for the evolution of eukaryotes. BMC Evol Biol 12: 32, 2012.
85. Tyurin VA, Tyurina YY, Feng W, Mnuskin A, Jiang J, Tang M, Zhang X, Zhao Q, Kochanek PM, Clark RS, Bayir H, and Kagan VE. Mass-spectrometric characterization of phospholipids and their primary peroxidation products in rat cortical neurons during staurosporineinduced apoptosis. J Neurochem 107: 1614-1633, 2008.
86. Tyurin VA, Tyurina YY, Jung MY, Tungekar MA, Wasserloos KJ, Bayir H, Greenberger JS, Kochanek PM, Shvedova AA, Pitt B, and Kagan VE. Mass-spectrometric analysis of hydroperoxy- and hydroxy-derivatives of cardiolipin and phosphatidylserine in cells and tissues induced by pro-apoptotic and pro-inflammatory stimuli. J Chromatogr B Analyt Technol Biomed Life Sci 877: 2863-2872, 2009.
87. Tyurina Y, Vikulina A, Kapralova V, Winnica D, Sanders L, Greenamyre T, Tyurin V, and Kagan V. Oxidized cardiolipins as a biomarker of mitochondrial dysfunction triggered by pesticide, rotenone. Suppl Toxicol Sci 138: 398, 2014.
88. Tyurina YY, Shvedova AA, Kawai K, Tyurin VA, Kommineni C, Quinn PJ, Schor NF, Fabisiak JP, and Kagan VE. Phospholipid signaling in apoptosis: peroxidation and externalization of phosphatidylserine. Toxicology 148: 93-101, 2000.
89. Tyurina YY, Tyurin VA, Epperly MW, Greenberger JS, and Kagan VE. Oxidative lipidomics of gamma-irradiationinduced intestinal injury. Free Radic Biol Med 44: 299-314, 2008.
90. Tyurina YY, Tyurin VA, Kapralova VI, Amoscato AA, Epperly MW, Greenberger JS, and Kagan VE. Massspectrometric characterization of phospholipids and their hydroperoxide derivatives in vivo: effects of total body irradiation. Methods Mol Biol 580: 153-183, 2009.
91. Tyurina YY, Tyurin VA, Kaynar AM, Kapralova VI, Wasserloos K, Li J, Mosher M, Wright L, Wipf P, Watkins S, Pitt BR, and Kagan VE. Oxidative lipidomics of hyperoxic acute lung injury: mass spectrometric characterization of cardiolipin and phosphatidylserine peroxidation. Am J Physiol Lung Cell Mol Physiol 299: L73-L85, 2010.
92. Tyurina YY, Kisin ER, Murray A, Tyurin VA, Kapralova VI, Sparvero LJ, Amoscato AA, Samhan-Arias AK, Swedin L, Lahesmaa R, Fadeel B, Shvedova AA, and Kagan VE. Global phospholipidomics analysis reveals selective pulmonary peroxidation profiles upon inhalation of single-walled carbon nanotubes. ACS Nano 5: 7342- 7353, 2011.
93. Tyurina YY, Tyurin VA, Kapralova VI, Wasserloos K, Mosher M, Epperly MW, Greenberger JS, Pitt BR, and Kagan VE. Oxidative lipidomics of gamma-radiation-induced lung injury: mass spectrometric characterization of cardiolipin and phosphatidylserine peroxidation. Radiat Res 175: 610-621, 2011.
94. Tyurina YY, Poloyac SM, Tyurin VA, Kapralov AA, Jiang JF, Anthonymuthu TS, Kapralova VI, Vikulina AS, Jung MY, Epperly MW, Mohammadyani D, Klein- Seetharaman J, Jackson TC, Kochanek PM, Pitt BR, Greenberger JS, Vladimirov YA, Bayir H, and Kagan VE. A mitochondrial pathway for biosynthesis of lipid mediators. Nat Chem 6: 542-552, 2014.
95. Ursini F, Maiorino M, and Gregolin C. The selenoenzyme phospholipid hydroperoxide glutathione peroxidase. Biochim Biophys Acta 839: 62-70, 1985.
96. van Vliet AR, Verfaillie T, and Agostinis P. New functions of mitochondria associated membranes in cellular signaling. Biochim Biophys Acta 1843: 2253-2262, 2014.
97. Vance JE and Tasseva G. Formation and function of phosphatidylserine and phosphatidylethanolamine inmammalian cells. Biochim Biophys Acta 1831: 543-554, 2013.
98. Venditti P, Di Stefano L, and Di Meo S. Mitochondrial metabolism of reactive oxygen species. Mitochondrion 13: 71-82, 2013.
99. Weinkam P, Zimmermann J, Romesberg FE, and Wolynes PG. The folding energy landscape and free energy excitations of cytochrome c. Acc Chem Res 43: 652-660, 2010.
100. Whited K, Baile MG, Currier P, and Claypool SM. Seven functional classes of Barth syndrome mutation. Hum Mol Genet 22: 483-492, 2013.
101. Williamson P and Schlegel RA. Transbilayer phospholipid movement and the clearance of apoptotic cells. Biochim Biophys Acta 1585: 53-63, 2002.
102. Wipf P, Xiao J, Jiang J, Belikova NA, Tyurin VA, Fink MP, and Kagan VE. Mitochondrial targeting of selective electron scavengers: synthesis and biological analysis of hemigramicidin-tempo conjugates. J Am Chem Soc 127: 12460-12461, 2005.
103. Yano H, Baranov SV, Baranova OV, Kim J, Pan Y, Yablonska S, Carlisle DL, Ferrante RJ, Kim AH, and Friedlander RM. Inhibition of mitochondrial protein import by mutant huntingtin. Nat Neurosci 17: 822-831, 2014.
104. Yin F, Sancheti H, and Cadenas E. Mitochondrial thiols in the regulation of cell death pathways. Antioxid Redox Signal 17: 1714-1727, 2012.